{
    "clinical_study": {
        "@rank": "137849", 
        "arm_group": [
            {
                "arm_group_label": "Lactobacillus plantarum 299v", 
                "arm_group_type": "Experimental", 
                "description": "Lactobacillus plantarum 299v"
            }, 
            {
                "arm_group_label": "Crytalline cellulose powder", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "In patients with IBS, will supplementation with a probiotic influence gut microflora and\n      thus improve clinical outcomes, as compared to no intervention?"
        }, 
        "brief_title": "Effect of Lactobacillus Plantarum 299v on Symptoms of Irritable Bowel Syndrome", 
        "condition": "Irritable Bowel Syndrome", 
        "condition_browse": {
            "mesh_term": "Irritable Bowel Syndrome"
        }, 
        "detailed_description": {
            "textblock": "Conduct a study on dietary intake and link variations in colon microflora to dietary\n      composition, faecal SCFAs and pathological markers of the colon.\n\n      Conduct an appropriately well designed randomised, double blind, placebo-controlled clinical\n      trial with L.plantarum 299v."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  fulfillment of the Rome II criteria for IBS,\n\n          -  availability of at least one colonoscopy within the last three years,\n\n          -  aged 18 or older at the time of screening,\n\n          -  provision of written informed consent,\n\n          -  commitment of availability throughout the 12 week study period.\n\n        Exclusion Criteria:\n\n          -  major abdominal surgery in the past other than other than appendectomy, caesarean\n             section, tubal laparoscopic cholecystectomy, abdominal wall hernia repair or/and\n             hysterectomy,\n\n          -  current use of antibiotics,\n\n          -  history of organic intestinal disease,\n\n          -  pregnant or breastfeeding mothers,\n\n          -  chronic infectious disease like HIV or tuberculosis, and\n\n          -  unable to understand English or Afrikaans."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "81", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01886781", 
            "org_study_id": "N10-08-270"
        }, 
        "intervention": [
            {
                "arm_group_label": "Lactobacillus plantarum 299v", 
                "intervention_name": "Lactobacillus plantarum 299v", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Crytalline cellulose powder", 
                "intervention_name": "placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "only constipation and diarrhea predominant", 
            "no mixed or alternating types"
        ], 
        "lastchanged_date": "June 21, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Port Elizabeth", 
                    "country": "South Africa", 
                    "state": "Eastern Cape", 
                    "zip": "6001"
                }, 
                "name": "Netcare Greenacres Hospital"
            }, 
            "investigator": {
                "last_name": "Cheryl Stevenson, M.Sc", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "South Africa"
        }, 
        "number_of_arms": "2", 
        "official_title": "Randomised Controlled Trial: Effect of Lactobacillus Plantarum 299v on Symptoms of Irritable Bowel Syndrome", 
        "overall_contact": {
            "email": "cheryl@retaildc.co.za", 
            "last_name": "Cheryl Stevenson, M.Sc", 
            "phone": "+270827514411"
        }, 
        "overall_official": {
            "affiliation": "Univeristy of Stellenbosch", 
            "last_name": "Cheryl Stevenson, M.Sc", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "South Africa: Health Research Ethics Committee, University of Stellenbosch", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The clinical severity of the IBS symptoms (pain and distension) was evaluated by the Francis Severity Score questionnaire (Francis 1997). The questionnaire is a validated tools for use in IBS.  The severity score contained five questions, each given a value from 0 (no symptoms) to 100 (most severe) for measuring the severity and frequency of abdominal pain.  The sum of scores of these questions was considered the severity score, with a maximum possible score of 500", 
            "measure": "A decrease in abdominal pain", 
            "safety_issue": "Yes", 
            "time_frame": "Total trial period 12 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01886781"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Stellenbosch", 
            "investigator_full_name": "Cheryl Stevenson", 
            "investigator_title": "Mrs", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University of Stellenbosch", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Nestle Nutrition Institute Africa (NNIA)", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "National Research Foundation (NRF) (RSA)", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "University of Stellenbosch", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2011", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}